IPG-007(Immunophage)

N/A

Report date: 2024/10/14 16:11:41
NMEFirst In Class

Base Information

Drug NameIPG-007(Immunophage)
Drug Alias NameIPG-007IPG007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor modulators
TargetsG-protein coupled receptor
Therapy Area/IndicationsImmunoglobulin G4-Related Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Immunophage Biotech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Immunophage Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsImmunoglobulin G4-Related Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A